By Hanna Vioque ( February 2, 2026, 2:05 PM GMT) -- Novartis has pushed back against Teva's invalidity claims over a supplementary protection certificate that extends protection for a hypertension treatment, accusing the generic drugs giant of preemptively filing claims before infringing the Swiss company's IP with a cheaper version. ...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.